Table 4 Influence of HDM or Ascaris sensitization on lung function parameters
Outcomes | All patients (n = 262) | Sensitization to Ascaris | HDM sensitization | ||||
|---|---|---|---|---|---|---|---|
Yes | No | p-value | Yes | No | p-value | ||
Continuous variables (mean ± SD) |  |  |  |  |  |  |  |
Predicted baseline FEV 1 (%) | 71.40 ± 20.61 | 70.38 ± 20.50 | 73.02 ± 20.75 | 0.31 | 71.03 ± 20.78 | 72.38 ± 20.27 | 0.64 |
Predicted post BD FEV 1 (%) | 77.70 ± 18.60 | 77.30 ± 18.11 | 78.32 ± 19.41 | 0.67 | 77.89 ± 18.60 | 77.21 ± 18.70 | 0.79 |
FEV1/FVC (%) | 86.08 ± 15.80 | 85.42 ± 16.07 | 87.14 ± 15.37 | 0.39 | 85.17 ± 15.88 | 88.48 ± 15.42 | 0.13 |
Categorical [n (%)] | Â | Â | Â | Â | Â | Â | Â |
Predicted baseline FEV1 < 80% | 158 (60.31) | 100 (62.5) | 58 (56.9) | 0.36 | 117 (61.6) | 41 (56.9) | 0.49 |
Bronchodilator responsiveness | 100 (38.2) | 67 (34.4) | 33 (28.0) | 0.11 | 81 (42.6) | 19 (26.4) | 0.01 |